[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @giconnectInfo GI CONNECT GI CONNECT posts on X about emerging, matterhorn the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::3359087302/interactions)  - X Week XXXXXXX -XX% - X Month XXXXXXXXX -XX% - X Months XXXXXXXXX +111% - X Year XXXXXXXXX +97% ### Mentions: X [#](/creator/twitter::3359087302/posts_active)  - X Week X +67% - X Month X -XX% - X Months XX +91% - X Year XX +43% ### Followers: XXXXX [#](/creator/twitter::3359087302/followers)  - X Week XXXXX +0.73% - X Month XXXXX +0.64% - X Months XXXXX +9% - X Year XXXXX +9.70% ### CreatorRank: undefined [#](/creator/twitter::3359087302/influencer_rank)  ### Social Influence [#](/creator/twitter::3359087302/influence) --- **Social category influence** [nba](/list/nba) XXXX% [finance](/list/finance) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [emerging](/topic/emerging) 12.5%, [matterhorn](/topic/matterhorn) XXXX% **Top accounts mentioned or mentioned by** [@diceeurope](/creator/undefined) [@waroncancer](/creator/undefined) [@efratdotan](/creator/undefined) [@pancan](/creator/undefined) [@drshubhampant](/creator/undefined) [@natpancfdn](/creator/undefined) [@letswinpc](/creator/undefined) [@helops79](/creator/undefined) [@profkherrmann](/creator/undefined) [@oncbrothers](/creator/undefined) [@nanets1](/creator/undefined) [@gicancer](/creator/undefined) [@ncukcharity](/creator/undefined) [@andreasart](/creator/undefined) [@lizzysmyth1](/creator/undefined) ### Top Social Posts [#](/creator/twitter::3359087302/posts) --- Top posts by engagements in the last XX hours "New #NETs video 📹 Expert perspectives on PRRT and emerging strategies in #neuroendocrine tumours Explore diagnostic strategies pt selection based on clinical trials safety profiles/AE management future directions & more w/ Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter" [X Link](https://x.com/giconnectInfo/status/1975172900702269637) [@giconnectInfo](/creator/x/giconnectInfo) 2025-10-06T12:14Z 2195 followers, XX engagements "Just released Gastric & #gastroesophageal cancer update from #ESMO25 📺 Dr @LizzySmyth1 shares her #gastric & GE cancer highlights & reviews the latest data from the #MATTERHORN trial See more updates from ESMO: This independent programme is supported by COR2ED #MedEd #GastricCancer #GIcancer" [X Link](https://x.com/giconnectInfo/status/1979911913619194182) [@giconnectInfo](/creator/x/giconnectInfo) 2025-10-19T14:05Z 2198 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
GI CONNECT posts on X about emerging, matterhorn the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.
Social category influence nba XXXX% finance XXXX% travel destinations XXXX%
Social topic influence emerging 12.5%, matterhorn XXXX%
Top accounts mentioned or mentioned by @diceeurope @waroncancer @efratdotan @pancan @drshubhampant @natpancfdn @letswinpc @helops79 @profkherrmann @oncbrothers @nanets1 @gicancer @ncukcharity @andreasart @lizzysmyth1
Top posts by engagements in the last XX hours
"New #NETs video 📹 Expert perspectives on PRRT and emerging strategies in #neuroendocrine tumours Explore diagnostic strategies pt selection based on clinical trials safety profiles/AE management future directions & more w/ Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter"
X Link @giconnectInfo 2025-10-06T12:14Z 2195 followers, XX engagements
"Just released Gastric & #gastroesophageal cancer update from #ESMO25 📺 Dr @LizzySmyth1 shares her #gastric & GE cancer highlights & reviews the latest data from the #MATTERHORN trial See more updates from ESMO: This independent programme is supported by COR2ED #MedEd #GastricCancer #GIcancer"
X Link @giconnectInfo 2025-10-19T14:05Z 2198 followers, XXX engagements
/creator/x::giconnectInfo